APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fc Fusion Protein for Autoimmune Disease

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Fc Fusion Protein for Autoimmune Disease Market Outlook and Growth Opportunities 2026

2 January 2026196 pages

Choose your research edition.

Industry ResearchFc Fusion Protein for Autoimmune Disease Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Fc Fusion Protein for Autoimmune Disease Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Fc Fusion Protein for Autoimmune Disease Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fc Fusion Protein for Autoimmune Disease Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Fc Fusion Protein for Autoimmune Disease Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Fc Fusion Protein for Autoimmune Disease market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Fc Fusion Protein for Autoimmune Disease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Fc Fusion Protein for Autoimmune Disease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fc Fusion Protein for Autoimmune Disease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Fc Fusion Protein for Autoimmune Disease market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Fc Fusion Protein for Autoimmune Disease market include Pfizer, Amgen, Celgen Biopharma, Bristol-Myers Squibb and 3SBIO, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Fc Fusion Protein for Autoimmune Disease market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Fc Fusion Protein for Autoimmune Disease and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Fc Fusion Protein for Autoimmune Disease revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Fc Fusion Protein for Autoimmune Disease market.

Fc Fusion Protein for Autoimmune Disease Segment by Company

Pfizer

Amgen

Celgen Biopharma

Bristol-Myers Squibb

3SBIO

Fc Fusion Protein for Autoimmune Disease Segment by Type

Orencia

Enbrel

Fc Fusion Protein for Autoimmune Disease Segment by Application

Rheumatoid Arthritis

Ankylosing Spondylitis

Psoriatic Arthritis

Juvenile Idiopathic Arthritis

Other

Fc Fusion Protein for Autoimmune Disease Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Fc Fusion Protein for Autoimmune Disease status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Fc Fusion Protein for Autoimmune Disease key companies, revenue, market share, and recent developments.

3. To split the Fc Fusion Protein for Autoimmune Disease breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Fc Fusion Protein for Autoimmune Disease market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Fc Fusion Protein for Autoimmune Disease significant trends, drivers, influence factors in global and regions.

6. To analyze Fc Fusion Protein for Autoimmune Disease competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fc Fusion Protein for Autoimmune Disease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fc Fusion Protein for Autoimmune Disease and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fc Fusion Protein for Autoimmune Disease.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Fc Fusion Protein for Autoimmune Disease industry.

Chapter 3: Detailed analysis of Fc Fusion Protein for Autoimmune Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Fc Fusion Protein for Autoimmune Disease in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Fc Fusion Protein for Autoimmune Disease in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Fc Fusion Protein for Autoimmune Disease Industry Trends Table 2. Fc Fusion Protein for Autoimmune Disease Industry Drivers Table 3. Fc Fusion Protein for Autoimmune Disease Industry Opportunities and Challenges Table 4. Fc Fusion Protein for Autoimmune Disease Industry Restraints Table 5. Global Fc Fusion Protein for Autoimmune Disease Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Fc Fusion Protein for Autoimmune Disease Revenue Share by Company (2021-2026) Table 7. Global Fc Fusion Protein for Autoimmune Disease Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Fc Fusion Protein for Autoimmune Disease Key Company Manufacturing Base & Headquarters Table 9. Global Fc Fusion Protein for Autoimmune Disease Company, Product Type & Application Table 10. Global Fc Fusion Protein for Autoimmune Disease Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Fc Fusion Protein for Autoimmune Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Orencia Table 15. Significant Companies of Enbrel Table 16. Global Fc Fusion Protein for Autoimmune Disease Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Fc Fusion Protein for Autoimmune Disease Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Fc Fusion Protein for Autoimmune Disease Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type (2021-2026) Table 20. Global Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Rheumatoid Arthritis Table 22. Significant Companies of Ankylosing Spondylitis Table 23. Significant Companies of Psoriatic Arthritis Table 24. Significant Companies of Juvenile Idiopathic Arthritis Table 25. Significant Companies of Other Table 26. Global Fc Fusion Protein for Autoimmune Disease Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Fc Fusion Protein for Autoimmune Disease Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Fc Fusion Protein for Autoimmune Disease Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application (2021-2026) Table 30. Global Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application (2027-2032) Table 31. Global Fc Fusion Protein for Autoimmune Disease Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Fc Fusion Protein for Autoimmune Disease Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Fc Fusion Protein for Autoimmune Disease Sales Value Share by Region (2021-2026) Table 34. Global Fc Fusion Protein for Autoimmune Disease Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Fc Fusion Protein for Autoimmune Disease Sales Value Share by Region (2027-2032) Table 36. Global Fc Fusion Protein for Autoimmune Disease Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Fc Fusion Protein for Autoimmune Disease Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Fc Fusion Protein for Autoimmune Disease Sales Value Market Share by Country (2021-2026) Table 39. Global Fc Fusion Protein for Autoimmune Disease Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Fc Fusion Protein for Autoimmune Disease Sales Value Market Share by Country (2027-2032) Table 41. Pfizer Company Information Table 42. Pfizer Business Overview Table 43. Pfizer Fc Fusion Protein for Autoimmune Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Pfizer Fc Fusion Protein for Autoimmune Disease Product Portfolio Table 45. Pfizer Recent Development Table 46. Amgen Company Information Table 47. Amgen Business Overview Table 48. Amgen Fc Fusion Protein for Autoimmune Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Amgen Fc Fusion Protein for Autoimmune Disease Product Portfolio Table 50. Amgen Recent Development Table 51. Celgen Biopharma Company Information Table 52. Celgen Biopharma Business Overview Table 53. Celgen Biopharma Fc Fusion Protein for Autoimmune Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Celgen Biopharma Fc Fusion Protein for Autoimmune Disease Product Portfolio Table 55. Celgen Biopharma Recent Development Table 56. Bristol-Myers Squibb Company Information Table 57. Bristol-Myers Squibb Business Overview Table 58. Bristol-Myers Squibb Fc Fusion Protein for Autoimmune Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Bristol-Myers Squibb Fc Fusion Protein for Autoimmune Disease Product Portfolio Table 60. Bristol-Myers Squibb Recent Development Table 61. 3SBIO Company Information Table 62. 3SBIO Business Overview Table 63. 3SBIO Fc Fusion Protein for Autoimmune Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. 3SBIO Fc Fusion Protein for Autoimmune Disease Product Portfolio Table 65. 3SBIO Recent Development Table 66. Research Programs/Design for This Report Table 67. Authors List of This Report Table 68. Secondary Sources Table 69. Primary Sources List of Figures Figure 1. Fc Fusion Protein for Autoimmune Disease Product Image Figure 2. Global Fc Fusion Protein for Autoimmune Disease Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fc Fusion Protein for Autoimmune Disease Market Size (2021-2032) & (US$ Million) Figure 4. Global Fc Fusion Protein for Autoimmune Disease Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Orencia Image Figure 8. Enbrel Image Figure 9. Global Fc Fusion Protein for Autoimmune Disease Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Fc Fusion Protein for Autoimmune Disease Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type (2021-2032) Figure 12. Rheumatoid Arthritis Image Figure 13. Ankylosing Spondylitis Image Figure 14. Psoriatic Arthritis Image Figure 15. Juvenile Idiopathic Arthritis Image Figure 16. Other Image Figure 17. Global Fc Fusion Protein for Autoimmune Disease Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Fc Fusion Protein for Autoimmune Disease Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application (2021-2032) Figure 20. Global Fc Fusion Protein for Autoimmune Disease Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Fc Fusion Protein for Autoimmune Disease Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Fc Fusion Protein for Autoimmune Disease Sales Value (2021-2032) & (US$ Million) Figure 23. North America Fc Fusion Protein for Autoimmune Disease Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Fc Fusion Protein for Autoimmune Disease Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Fc Fusion Protein for Autoimmune Disease Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Fc Fusion Protein for Autoimmune Disease Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Fc Fusion Protein for Autoimmune Disease Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Fc Fusion Protein for Autoimmune Disease Sales Value (2021-2032) & (US$ Million) Figure 29. South America Fc Fusion Protein for Autoimmune Disease Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Fc Fusion Protein for Autoimmune Disease Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Fc Fusion Protein for Autoimmune Disease Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Orencia
  • Enbrel
Applications
  • Rheumatoid Arthritis
  • Ankylosing Spondylitis
  • Psoriatic Arthritis
  • Juvenile Idiopathic Arthritis
  • Other
Companies covered
  • Pfizer
  • Amgen
  • Celgen Biopharma
  • Bristol-Myers Squibb
  • 3SBIO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Fc Fusion Protein for Autoimmune Disease Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Fc Fusion Protein for Autoimmune Disease Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Fc Fusion Protein for Autoimmune Disease Market Dynamics
  1. 2.1 Fc Fusion Protein for Autoimmune Disease Industry Trends
  2. 2.2 Fc Fusion Protein for Autoimmune Disease Industry Drivers
  3. 2.3 Fc Fusion Protein for Autoimmune Disease Industry Opportunities and Challenges
  4. 2.4 Fc Fusion Protein for Autoimmune Disease Industry Restraints
3 Fc Fusion Protein for Autoimmune Disease Market by Company
  1. 3.1 Global Fc Fusion Protein for Autoimmune Disease Company Revenue Ranking in 2025
  2. 3.2 Global Fc Fusion Protein for Autoimmune Disease Revenue by Company (2021-2026)
  3. 3.3 Global Fc Fusion Protein for Autoimmune Disease Company Ranking (2024-2026)
  4. 3.4 Global Fc Fusion Protein for Autoimmune Disease Company Manufacturing Base and Headquarters
  5. 3.5 Global Fc Fusion Protein for Autoimmune Disease Company Product Type and Application
  6. 3.6 Global Fc Fusion Protein for Autoimmune Disease Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Fc Fusion Protein for Autoimmune Disease Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Fc Fusion Protein for Autoimmune Disease Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Fc Fusion Protein for Autoimmune Disease Market by Type
  1. 4.1 Fc Fusion Protein for Autoimmune Disease Type Introduction
  2. 4.1.1 Orencia
  3. 4.1.2 Enbrel
  4. 4.2 Global Fc Fusion Protein for Autoimmune Disease Sales Value by Type
  5. 4.2.1 Global Fc Fusion Protein for Autoimmune Disease Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Fc Fusion Protein for Autoimmune Disease Sales Value by Type (2021-2032)
  7. 4.2.3 Global Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type (2021-2032)
5 Fc Fusion Protein for Autoimmune Disease Market by Application
  1. 5.1 Fc Fusion Protein for Autoimmune Disease Application Introduction
  2. 5.1.1 Rheumatoid Arthritis
  3. 5.1.2 Ankylosing Spondylitis
  4. 5.1.3 Psoriatic Arthritis
  5. 5.1.4 Juvenile Idiopathic Arthritis
  6. 5.1.5 Other
  7. 5.2 Global Fc Fusion Protein for Autoimmune Disease Sales Value by Application
  8. 5.2.1 Global Fc Fusion Protein for Autoimmune Disease Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Fc Fusion Protein for Autoimmune Disease Sales Value by Application (2021-2032)
  10. 5.2.3 Global Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application (2021-2032)
6 Fc Fusion Protein for Autoimmune Disease Regional Value Analysis
  1. 6.1 Global Fc Fusion Protein for Autoimmune Disease Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Fc Fusion Protein for Autoimmune Disease Sales Value by Region (2021-2032)
  3. 6.2.1 Global Fc Fusion Protein for Autoimmune Disease Sales Value by Region: 2021-2026
  4. 6.2.2 Global Fc Fusion Protein for Autoimmune Disease Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Fc Fusion Protein for Autoimmune Disease Sales Value (2021-2032)
  7. 6.3.2 North America Fc Fusion Protein for Autoimmune Disease Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Fc Fusion Protein for Autoimmune Disease Sales Value (2021-2032)
  10. 6.4.2 Europe Fc Fusion Protein for Autoimmune Disease Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Fc Fusion Protein for Autoimmune Disease Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Fc Fusion Protein for Autoimmune Disease Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Fc Fusion Protein for Autoimmune Disease Sales Value (2021-2032)
  16. 6.6.2 South America Fc Fusion Protein for Autoimmune Disease Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Fc Fusion Protein for Autoimmune Disease Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Fc Fusion Protein for Autoimmune Disease Sales Value Share by Country, 2025 VS 2032
7 Fc Fusion Protein for Autoimmune Disease Country-level Value Analysis
  1. 7.1 Global Fc Fusion Protein for Autoimmune Disease Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Fc Fusion Protein for Autoimmune Disease Sales Value by Country (2021-2032)
  3. 7.2.1 Global Fc Fusion Protein for Autoimmune Disease Sales Value by Country (2021-2026)
  4. 7.2.2 Global Fc Fusion Protein for Autoimmune Disease Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Fc Fusion Protein for Autoimmune Disease Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Fc Fusion Protein for Autoimmune Disease Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Fc Fusion Protein for Autoimmune Disease Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Pfizer
  2. 8.1.1 Pfizer Company Information
  3. 8.1.2 Pfizer Business Overview
  4. 8.1.3 Pfizer Fc Fusion Protein for Autoimmune Disease Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Pfizer Fc Fusion Protein for Autoimmune Disease Product Portfolio
  6. 8.1.5 Pfizer Recent Developments
  7. 8.2 Amgen
  8. 8.2.1 Amgen Company Information
  9. 8.2.2 Amgen Business Overview
  10. 8.2.3 Amgen Fc Fusion Protein for Autoimmune Disease Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Amgen Fc Fusion Protein for Autoimmune Disease Product Portfolio
  12. 8.2.5 Amgen Recent Developments
  13. 8.3 Celgen Biopharma
  14. 8.3.1 Celgen Biopharma Company Information
  15. 8.3.2 Celgen Biopharma Business Overview
  16. 8.3.3 Celgen Biopharma Fc Fusion Protein for Autoimmune Disease Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Celgen Biopharma Fc Fusion Protein for Autoimmune Disease Product Portfolio
  18. 8.3.5 Celgen Biopharma Recent Developments
  19. 8.4 Bristol-Myers Squibb
  20. 8.4.1 Bristol-Myers Squibb Company Information
  21. 8.4.2 Bristol-Myers Squibb Business Overview
  22. 8.4.3 Bristol-Myers Squibb Fc Fusion Protein for Autoimmune Disease Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bristol-Myers Squibb Fc Fusion Protein for Autoimmune Disease Product Portfolio
  24. 8.4.5 Bristol-Myers Squibb Recent Developments
  25. 8.5 3SBIO
  26. 8.5.1 3SBIO Company Information
  27. 8.5.2 3SBIO Business Overview
  28. 8.5.3 3SBIO Fc Fusion Protein for Autoimmune Disease Revenue and Gross Margin (2021-2026)
  29. 8.5.4 3SBIO Fc Fusion Protein for Autoimmune Disease Product Portfolio
  30. 8.5.5 3SBIO Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst